Abstract. The association of familial hypogonadism with progressive cerebellar ataxia is only rarely encountered, and the exact link between the symptoms remains unknown. We report here two sisters presenting with Holmes type cerebellar ataxia, hypogonadotropic hypogonadism and retinochoroidal degeneration recently diagnosed as Boucher-Neuhauser syndrome. There was consanguinity between the parents of the affected individuals and the condition seemed to be inherited as an autosomal recessive defect. On endocrinological examinations, in both cases, the responses of LH and FSH to LH-RH (100 jug) were impaired even after repetitive stimulation with LH-RH (400 jig, 7 days), suggesting that the hypogonadism was due to a primary pituitary disturbance. Impaired GH responses to GRF (100 ug) and insulin-induced hypoglycemia (0.1 U/kg) were also noted. The two sisters shared an almost identical clinical and endocrinological picture. Their karyotypes were 46, XX. They had been treated for primary and secondary amenorrhea at the age of 20 years and neurological problems had started at the age of 30 years. This unique family displays clinical evidence of a possible common mechanism responsible for a progressive hypothalamo-pituitary and cerebellar impairment of late onset.
SYSTEMATIC cerebellar degeneration
is often difficult to clarify with any precision, and in most cases, the etiology remains unknown.
Corticocerebellar atrophy (CCA) and olivocerebellar atrophy (OCA) most probably represent the same degenerative disorder. They are characterized by the appearance of a pure, progressive pan cerebellar syndrome associated with an autosomal dominant pattern of inheritance. Occasionally sporadic cases and cases with autosomal recessive inheritance also may occur. The age of onset is usually in the fourth to sixth decades, but onset as early as the second and as late as the seventh decade has been reported. The abnormality appears first in the legs, resulting in unsteadiness of stance and a gait of a peculiar wavering, lurching character typical of cerebellar ataxia. This phenomenon has been correlated with the localization of changes in the superior vermis of the cerebellum and adjacent parts of the cerebellar cortex. using the name of the first authors of two earlier reports [14] . Recently, we examined two sisters who seemed to suffer from a condition almost exactly compatible with this syndrome, and had the opportunity to perform a careful endocrinological evaluation.
Here we report a new variant of Boucher-Neuhauser syndrome.
Case 1 Case Reports
A 52-year-old woman, the product of a normal pregnancy and delivery, was admitted for evaluation of an unsteady gait, recurrent bone fractures and hypercalcemia.
There was consanguinity between the parents.
They are second cousins. The patient never menstruated. She first noticed unsteady gait and hair loss at about the age of 20. She had been treated for primary amenorrhea for 6 years since the age of 28 years, and had had a child at the age of 35 The laboratory data for case 2 are also shown in Table 1 . The serum Ca level was at the normal upper limit (10.0 mg/dl), but enhanced urinary Ca excretion was noted (145.6 mg/day).
Ccr was normal.
Moderate hyperlipidemia and hyperuricemia (total cholesterol: 263 mg/dl, triglyceride: 296 mg/dl, uric acid: 6.8 mg/dl) were found. CUA/ Ccr was slightly decreased (0.069). For other routine chemistries, the urinalysis was normal. The karyotype was 46 XX.
Endocrinological evaluation
The serum basal hormone levels of both patients are summarized in Table 2 . The low estradiol (E2) levels, together with low luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels are consistent with hypogonadotropic hypogonadism. Serum progesterone levels were below the normal lower limit.
Serum growth hormone (GH) and somatomedin C levels were also low. In case 1, serum levels of intact parathyroid hormone (PTH), m-PTH, c-PTH were slightly elevated.
The basal levels of other hormones were almost all within normal limits.
Pituitary hormone responses to provocation tests in both cases are shown in were normal.
Radiological evaluation
Magnetic resonance imaging (MRI) of the brain showed marked cerebellar atrophy, while the brain stem was intact (Fig. 1) . There was no evidence of parathyroid gland swelling on echogram, computed tomography (CT) or technetium-thallium subtraction scanning. Since these two sisters had common histories of recurrent bone fractures, bone mineral density (BMD) was evaluated by the dual energy X-ray absorptiometry (DXA) method. The total BMD and L2-L4 BMD of cases 1 and 2 were 0.891 ± 0.01 and 0.896 ± 0.01 g/cm2, respectively (% age matched: 86 ± 3 % and 91 ± 3 %, respectively), and 0.738 ± 0.01 and 0.706 ± 0.01 g/cm2, respectively (% age matched: 71 ± 3 % and 75 ± 3 %, respectively), suggesting osteoporotic changes. Table 4 . Most families which have been reported are compatible with autosomal recessive inheritance, although Volpe et a1, reported a family for which an X-linked recessive inheritance was suggested.
The association of hypogonadism with cerebellar or spinocerebellar ataxia was first described by Holmes, and in most cases reported since, a deficiency in gonadotropin secretion has been demonstrated.
The responses of LH and FSH to LH-RH (100 #g) were impaired even after repetitive stimulation with LH-RH (400 µg, 7 days), pointing strongly to pituitary hypogonadism. It is reasonable to hypothesize that either the LH-RH receptor itself or a post LH-RH receptor signaling pathway would be impaired in these cases. Recently, the complementary DNA (cDNA) encoding the LH-RH receptor has been cloned and its sequence has been determined [20] [21] [22] . Southern blot analysis with the cDNA from the leucocytes of these sisters and normal Japanese women with the full length human LH-RH receptor as a probe failed to indicate any defect in the LH-RH receptor gene in the patient's sample. Although identical southern blot analysis does not exclude a small gene alteration which renders the LH-RH receptor non functional, such as a point mutation within the coding region or a promoter defect, these possibilities seem to be very unlikely. As Boucher-Neuhauser syndrome has many clinical features in addition to the loss of LH-RH responsiveness seen in our patients, it seems likely to that any gene lesion present would be large enough to affect multiple genes and thus would be readily apparent in the southern blot analysis. Further studies will be necessary to clarify the cause of hypogonadotropic hypogonadism. Serum GH responses to insulin-induced hypoglycemia (regular insulin 0.1 U/kg) were impaired in both cases, while in case 1 GH slightly responded to GRF (100 with an increase in hepatic LDL receptor activity, and that the increase in hepatic LDL receptor activity during pregnancy may be due to the action of estrogens.
In addition, exogenous estradiol suppresses the activity of hepatic lipase, which is thought to play a physiological role in regulating the conversion of very low density lipoprotein (VLDL) and intermediate density lipoprotein (IDL) to LDL, leading to decreased synthesis of LDL cholesterol and total cholesterol [27] . On the other hand, it has been well known that there is a sex difference in uric acid metabolism. The average serum uric acid level of men is somewhat higher than that of women. Mikkelsen et al.
[28] undertook serum uric acid determinations in order to define the distribution characteristics of serum uric acid levels in a natural population, and to evaluate the importance of age and sex as variables in relation to the serum uric acid level. For female subjects, there was a slight rise in serum uric acid values beyond puberty but the curve soon falls again and plateaus at a level of about 4.0 mg/ dl until the age of menopause, when in the early fifties it rises gradually to closely approach that of male subjects. It is therefore reasonable to speculate that estrogens may play a role in preventing the increase in serum uric acid possibly by increasing uric acid clearance from the blood or by blocking the synthesis of uric acid. Marked osteoporosis was also observed in these patients. Estrogen increases bone mass by suppressing bone turnover through several mechanisms as follows: estrogen acts directly on human bone cells through a classical estrogen receptor-mediated mechanism [29, 30] . 17 /3-Estradiol has direct effects on bone consistent with known effects of decreasing bone resorption [31] , and estrogen inhibits the production of interleukin 1, one of the pathogenetical factors in osteoporosis in the monocyte [32] . For the reasons described above, long term estrogen deficiency accelerates osteoporosis and other metabolic disorders.
The cause of the hypocalciuric hypercalcemia seen in case 1 remains unclear. Usually hypocalciuric hypercalcemia is a familial disease with autosomal dominant inheritance [33] [34] [35] [36] . Most recently, cDNA encoding an extracellular Cat+-sensing receptor has been cloned from the bovine parathyroid gland and well characterized [37] . The cDNA encodes a predicted 120 kd polypeptide containing a large extracellular domain and seven membrane-spanning regions characteristic of the superfamily of G protein-coupled cell surface receptors. In addition to parathyroid tissue, the receptor is also expressed in regions of the kidney involved in Cat+-regulated Ca2+ and Mg2+ reabsorption.
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